The aim of this research was to determine the influence of ulinastatin on nondepolarising muscle relaxants Rocuronium and Cisatracurium.
Age range
25 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Onset time
Timeframe: 1 day
RT1
Timeframe: 1 day
RT2
Timeframe: 1 day
RT3
Timeframe: 1 day
RT4
Timeframe: 1 day
Duration of moderate neuromuscular block (RT1-RT4)
Timeframe: 1 day
Duration 25%
Timeframe: 1 day
Duration 50%
Timeframe: 1 day
Duration TOF 0.7
Timeframe: 1 day
Recovery TOF 0.7 period
Timeframe: 1 day